We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
109 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Daylong Sensitive SPF50 Face Mineral Cream.
-
Australian public assessment report (AusPar)Nemluvio (nemolizumab) has been approved to treat moderate-to-severe atopic dermatitisin combination with topical corticosteroids and/ or topical calcineurin inhibitors in adults and patients aged 12 years and above who weigh at least 30 kg and who are candidates for systemic therapy. Nemluvio has also been approved for the treatment of adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.
-
Cancellation by sponsorRequested by Galderma Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NEMLUVIO nemolizumab 30mg powder and solution for injection pre filled pen.
-
Prescription medicine registrationActive ingredients: nemolizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Galderma Australia Pty Ltd - Restylane Skinboosters Vital Light Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Daily Defence Cream SPF 50.
-
Cancellation by sponsorRequested by Galderma Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cetaphil Daily Defence Cream SPF50.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DIFFERIN ACNE TREATMENT adapalene 1 mg/g cream tube.